Clonmel-based Labour MEP for Munster, Phil Prendergast, gave her reaction to news that Abbott is to make 200 of its workers redundant.
“The announcement from the medical devices firm, Abbott, that it is seeking 200 redundancies from its vascular facility in Clonmel is very distressing news for the workforce, their families, and the wider community.
“I hope that, during the month-long consultation phase that will now begin, Abbott will engage constructively with the Clonmel-based workers to find the best possible outcome for its employees.
“My understanding is that the company will not renew the positions of dozens of contract workers after they expire at the end of next month.
“The company must give all workers in that situation the full picture in terms of its intentions and their entitlements as soon as possible.
“Fortunately, Abbott is signalling that the Clonmel facilities remain a strategic asset for their vascular manufacturing operation across the globe.
“The company has stated that its Clonmel facilities will focus on more advanced medical devices, and I hope that as many of the current workforce as possible will be part of that new phase in the life of Abbott’s Clonmel site.
“I am anxious to hear further details regarding the need for such a significant number of redundancies sought, from a total workforce of more than 1,400.”